Form 4 for ATOS ATOSSA THERAPEUTICS, INC.
Accepted 2024-04-11 00:00:00 ET · period of report 2024-04-10 · accession 0000950170-24-043690 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-11 | 2024-04-10 | ATOS | Finn Jonathan | Dir | P - Purchase | $1.77 | +25.0K | 25.0K | New | +$44.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-10 | P | A | 25,000 | $1.77 | 25,000 | D | — | — | (F1) The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $1.74 to $1.78. Upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, The Reporting Person will provide full information regarding the number of shares purchased at each separate price. |